Multi-Modality Treatment in Basal Cell Carcinoma
1 Views
administrator
07/14/23
Panelists Keith T. Flaherty, MD; Jonathan S. Zager, MD; Georgina Long, BSc, MBBS; Jason J. Luke, MD; and Jeffrey S. Weber, MD; discuss how hedgehog pathway inhibitors change how patients with advanced basal cell carcinoma are treated and provide thoughts on the future of melanoma.
-
Category
Show more
Facebook Comments
No comments found